{
  "symbol": "EPRX",
  "company_name": "Eupraxia Pharmaceuticals Inc",
  "ir_website": "https://eupraxiapharma.com/investors/default.aspx",
  "structured_data": [
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "Eupraxia Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial",
          "url": "https://eupraxiapharma.com/news/2024-positive-topline-results-phase-2-trial",
          "content": "[Skip to main content](#maincontent)\n\nLoading ...\n\nLoading ...\n\n[![Eupraxia Pharmaceutical Inc. Logo](//s27.q4cdn.com/842820706/files/design/logo.png)](/)\n\nSite Search\n\nsearch\n\nSearch query \n\n# Page Not Found\n\n## Site Map\n\nWe're sorry, but there is no page on the site that matches your entry. It is possible you typed the address incorrectly, or the page may no longer exist. You may wish to try another entry or choose from the links below, which we hope will help you find what you are looking for.\n\nIf you believe that this page should exist, please send an email to support@q4inc.com explaining the page you were trying to access.\n\nThanks for your patience, understanding, and help.\n\n[![Eupraxia Pharmaceutical Inc. Logo](//s27.q4cdn.com/842820706/files/design/logo-footer.png)](/)\n\n## Quick Links\n\n  * [About Us](https://eupraxiapharma.com/about-us/our-core-values/default.aspx)\n  * [Our Science](https://eupraxiapharma.com/our-science/our-technology/default.aspx)\n  * [Investors](https://eupraxiapharma.com/investors/default.aspx)\n\n\n\n## [Contact Us](/contact/default.aspx)\n\nEupraxia Pharmaceuticals 201-2067 Cadboro Bay Rd. Victoria BC, Canada, V8R 5G4\n\n250-590-3968\n\n  * [Privacy Policy](https://eupraxiapharma.com/privacy-policy/default.aspx)\n  * [Terms of Use](https://eupraxiapharma.com/terms-of-use/default.aspx)\n\n\n\n  * [(opens in new window)](https://twitter.com/eupraxia_pharma?lang=en)\n  * [(opens in new window)](https://www.linkedin.com/company/2813136/admin/)\n\n\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Q1 2024 Financial Results",
          "url": "https://eupraxiapharma.com/financial-reports/q1-2024-results.pdf",
          "content": "Error extracting PDF content: 404 Client Error: Not Found for url: https://eupraxiapharma.com/financial-reports/q1-2024-results.pdf"
        }
      ]
    },
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Eupraxia Secures Additional Funding for Clinical Development",
          "url": "https://eupraxiapharma.com/press-releases/2024-funding-secured",
          "content": "[Skip to main content](#maincontent)\n\nLoading ...\n\n[Read More of NASDAQ: EPRX stock information](/investors/stock-information/default.aspx#stock-quote)\n\nNASDAQ: EPRX3.35-0.10 ( -2.90% )Vol: 11,170Pricing delayed by 20 minutes. Last Updated 11/29/2024 12:55 PM\n\n[![Eupraxia Pharmaceutical Inc. Logo](//s27.q4cdn.com/842820706/files/design/logo.png)](/)\n\nSite Search\n\nsearch\n\nSearch query \n\n# Page Not Found\n\n## Site Map\n\nWe're sorry, but there is no page on the site that matches your entry. It is possible you typed the address incorrectly, or the page may no longer exist. You may wish to try another entry or choose from the links below, which we hope will help you find what you are looking for.\n\nIf you believe that this page should exist, please send an email to support@q4inc.com explaining the page you were trying to access.\n\nThanks for your patience, understanding, and help.\n\n[![Eupraxia Pharmaceutical Inc. Logo](//s27.q4cdn.com/842820706/files/design/logo-footer.png)](/)\n\n## Quick Links\n\n  * [About Us](https://eupraxiapharma.com/about-us/our-core-values/default.aspx)\n  * [Our Science](https://eupraxiapharma.com/our-science/our-technology/default.aspx)\n  * [Investors](https://eupraxiapharma.com/investors/default.aspx)\n\n\n\n## [Contact Us](/contact/default.aspx)\n\nEupraxia Pharmaceuticals 201-2067 Cadboro Bay Rd. Victoria BC, Canada, V8R 5G4\n\n250-590-3968\n\n  * [Privacy Policy](https://eupraxiapharma.com/privacy-policy/default.aspx)\n  * [Terms of Use](https://eupraxiapharma.com/terms-of-use/default.aspx)\n\n\n\n  * [(opens in new window)](https://twitter.com/eupraxia_pharma?lang=en)\n  * [(opens in new window)](https://www.linkedin.com/company/2813136/admin/)\n\n\n"
        }
      ]
    }
  ]
}